Skip to main content
. 2021 Nov 12;13(11):1916. doi: 10.3390/pharmaceutics13111916

Figure 4.

Figure 4

Figure 4

Tabletability (a), compressibility (b) and compactability (c) profiles of the tablets containing lyophilized cyclodextrin-based Polygoni cuspidati extract (formulations F1–F6).